DI MAGNO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.267
EU - Europa 1.066
AS - Asia 291
AF - Africa 11
SA - Sud America 7
OC - Oceania 4
Totale 2.646
Nazione #
US - Stati Uniti d'America 1.257
IT - Italia 673
SG - Singapore 113
SE - Svezia 99
DE - Germania 97
CN - Cina 65
IN - India 56
FI - Finlandia 49
IE - Irlanda 35
GB - Regno Unito 20
ID - Indonesia 17
BG - Bulgaria 16
UA - Ucraina 15
BE - Belgio 14
CA - Canada 10
TR - Turchia 10
CH - Svizzera 9
FR - Francia 9
RO - Romania 9
TG - Togo 9
HK - Hong Kong 6
HR - Croazia 5
JP - Giappone 5
AU - Australia 4
AR - Argentina 3
IR - Iran 3
KZ - Kazakistan 3
NL - Olanda 3
RU - Federazione Russa 3
BT - Bhutan 2
ES - Italia 2
MY - Malesia 2
PL - Polonia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
BO - Bolivia 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
PK - Pakistan 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 2.646
Città #
Rome 353
Fairfield 193
Chandler 112
Ashburn 107
Seattle 88
Houston 85
Singapore 77
Woodbridge 75
Cambridge 59
Wilmington 55
Santa Clara 38
Dublin 34
Munich 32
Helsinki 31
San Paolo di Civitate 31
Dearborn 25
Princeton 24
Lawrence 22
New York 22
Ann Arbor 21
Fremont 21
Jakarta 17
Beijing 16
Milan 16
Sofia 16
Grafing 15
Millbury 15
San Diego 14
Plano 13
Andover 9
Bremen 9
Lomé 9
Florence 8
Palermo 8
Boardman 7
Boston 7
Brussels 7
Cerveteri 7
Latina 7
Hong Kong 6
Istanbul 6
Fiuggi 5
Frankfurt am Main 5
Los Angeles 5
Norwalk 5
Phoenix 5
Siano 5
Tianjin 5
Toronto 5
Zagreb 5
Alatri 4
Bari 4
Denver 4
Fasano 4
Hefei 4
Lappeenranta 4
Redwood City 4
Castel Gandolfo 3
Federal 3
Irpin 3
Köseköy 3
Leuven 3
Mannheim 3
Menlo Park 3
Nanchang 3
Nanjing 3
Naples 3
Nürnberg 3
Oxford 3
Pescara 3
Reggio Calabria 3
Reggio Emilia 3
Taranto 3
Washington 3
Astana 2
Baotou 2
Busto Arsizio 2
Bühl 2
Carson 2
Cassano delle Murge 2
Des Moines 2
Dijon 2
Jacksonville 2
Kyiv 2
Lommiswil 2
London 2
Machiya 2
Melbourne 2
Montréal 2
Moscow 2
Napoli 2
Ottawa 2
Padova 2
Padula 2
Philadelphia 2
Prato 2
Pune 2
San Benedetto del Tronto 2
Shenyang 2
Tashkent 2
Totale 1.893
Nome #
Drug design and synthesis of first in class PDZ1 targeting NHERF1 inhibitors as anticancer agents 171
Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation 140
Non-canonical Hedgehog/ampk-mediated control of polyamine metabolism supports neuronal and medulloblastoma cell growth 137
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP 135
Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype 128
The energy sensor AMPK regulates Hedgehog signaling in human cells through a unique Gli1 metabolic checkpoint 114
Phenformin inhibits hedgehog-dependent tumor growth through a complex i-independent redox/corepressor module 113
Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation 111
Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. 111
KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2 109
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response 107
Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation 101
Digging a hole under Hedgehog: Downstream inhibition as an emerging anticancer strategy 94
Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth 87
Sulfonamide inhibitors of beta-catenin signaling as anticancer agents with different output on c-Myc 85
Determination of acetylation of the Gli transcription factors 84
The coactivator CRTC1 promotes cell proliferation and transformation via AP-1 84
Polyamine metabolism as a therapeutic target in hedgehog-driven basal cell carcinoma and medulloblastoma 69
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential 68
CNBP regulates wing development in Drosophila melanogaster by promoting IRES-dependent translation of dMyc 67
Gli2 Acetylation at Lysine 757 Regulates Hedgehog-Dependent Transcriptional Output by Preventing Its Promoter Occupancy 67
MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation 65
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 61
Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma 59
Enzymatic spermine metabolites induce apoptosis associated with increase of p53, caspase-3 and miR-34a in both neuroblastoma cells, SJNKP and the N-Myc-amplified form IMR5 57
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 54
Opposite effect of thyroid hormones on oxidative stress and on mitochondrial respiration in COVID-19 patients 54
TORCs/CRTCs: More than mere coincidence. 48
Discovery of novel human lactate dehydrogenase inhibitors. Structure-based virtual screening studies and biological assessment 42
Partial Truncation of the C-Terminal Domain of PTCH1 in Cancer Enhances Autophagy and Metabolic Adaptability 37
Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery 35
Targeting Gli acetylation in Shh-medulloblastoma: A successful preclinical approach 29
The Mechanism of Action of Biguanides: New Answers to a Complex Question 26
Targeting metabolic vulnerabilities to treat Shh medulloblastoma 24
Development of N-(4-(1 H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability 16
Totale 2.789
Categoria #
all - tutte 9.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020291 0 0 0 0 0 0 75 66 58 37 31 24
2020/2021339 17 22 10 30 32 21 32 11 39 78 33 14
2021/2022327 8 14 35 28 28 19 9 51 24 13 47 51
2022/2023545 70 110 25 52 54 49 14 39 85 6 32 9
2023/2024462 30 41 29 22 44 81 38 44 16 44 44 29
2024/2025424 25 21 45 101 90 132 10 0 0 0 0 0
Totale 2.789